Diabetic kidney disease often develops quietly over years, making early screening essential. Experts highlight the importance of regular urine and kidney function tests in individuals with type 2 diabetes to prevent significant long-term damage.
Diabetes is often discussed in terms of blood sugar, but its reach is much wider. One of the organs most vulnerable to long-term damage is the kidney, and diabetic kidney disease is a major cause of chronic kidney disease and kidney failure. According to Greater Kashmir, the condition can progress quietly for years, leaving a person with substantial damage while feeling entirely well.
That silent course is what makes the disease so dangerous. High blood sugar over time can injure the small blood vessels and filtering units in the kidneys long before any obvious warning signs appear. Greater Kashmir notes that many people wrongly expect pain, reduced urine output or swelling before kidney trouble shows up, yet early disease often produces no symptoms at all.
By the time swelling around the eyes or feet, fatigue, poor appetite, nausea, itching or breathlessness develop, kidney function may already be significantly impaired. The National Kidney Foundation says the urine albumin-to-creatinine ratio, or uACR, can detect albumin in urine, an early marker of kidney damage, while the Centers for Disease Control and Prevention says a result of 30 or above may indicate kidney disease. The kidney groups also say persistent albuminuria is a principal marker of kidney damage and should be screened for in patients with chronic kidney disease.
Greater Kashmir says a recent review of Indian studies estimated that about 44% of people with type 2 diabetes may have diabetic kidney disease, underscoring the scale of the problem. That is why screening should not wait for symptoms. In line with current diabetes guidance, people with type 2 diabetes should have both uACR and estimated glomerular filtration rate, or eGFR, checked at least once a year. Early detection gives doctors a better chance to slow progression through blood sugar and blood pressure control, kidney-protective medicines such as some SGLT2 inhibitors or renin-angiotensin system drugs, and careful attention to cardiovascular risk factors.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
